Information  X 
Enter a valid email address

Alpha Real Tst Ltd (ARTL)

  Print      Mail a friend

Tuesday 21 August, 2018

Alpha Real Tst Ltd

Transaction in Own Shares

RNS Number : 4091Y
Alpha Real Trust Limited
21 August 2018
 

LEI: 213800BMY95CP6CYXK69

 

21 August 2018

 

 

ALPHA REAL TRUST LIMITED ("ALPHA REAL TRUST" OR THE "COMPANY")

TRANSACTION IN OWN SHARES

                                

Alpha Real Trust announces that on 20 August 2018 it purchased 1,000 ordinary shares of no par value ("Ordinary Shares") at a price (before expenses) of 129.7 pence per share. The purchased shares will be held in treasury.

The ordinary share capital of the Company following the purchase will be 70,295,095 (including 6,703,586 shares held in treasury).

The total voting rights in Alpha Real Trust following the purchase of the Ordinary Shares will be 68,495,906 (this figure includes class A shares).

The total voting rights figure (68,495,906) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in Alpha Real Trust under the FCA's Disclosure and Transparency Rules.

For further information please contact:

 

Alpha Real Trust Limited

David Jeffreys, Chairman, Alpha Real Trust                                   +44 (0) 1481 231 100

Brad Bauman, Joint Fund Manager, Alpha Real Trust                    +44 (0) 20 7391 4700

Panmure Gordon, Broker to the Company

Richard Gray / Andrew Potts                                                           +44 (0) 20 7886 2500

 

Further information on the Company can be found on the Company's website: www.alpharealtrustlimited.com.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
POSLIFEDTVILFIT

a d v e r t i s e m e n t